SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001381980-13-000002
Filing Date
2013-07-17
Accepted
2013-07-17 16:12:11
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 20157
  Complete submission text file 0001381980-13-000002.txt   21659
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SECOND FLOOR MENLO PARK CA 94025
Business Address
Kjellson Nina S (Reporting) CIK: 0001381980 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 13972752